DIAGNOSIS OF CREUTZFELDT-JAKOB DISEASE BY WESTERN-BLOT IDENTIFICATION OF MARKER PROTEIN IN HUMAN-BRAIN TISSUE
DIAGNOSIS OF CREUTZFELDT-JAKOB DISEASE BY WESTERN-BLOT IDENTIFICATION OF MARKER PROTEIN IN HUMAN-BRAIN TISSUE
复制标题
DOI:
10.1056/nejm198602273140904
复制
发表时间:
1986-02-27
影响因子:
158.5
通讯作者:
GAJDUSEK, DC
中科院分区:
文献类型:
--
作者:
BROWN, P;COKERVANN, M;GAJDUSEK, DC
We tested purified preparations of brain tissue from 39 patietns with Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker syndrome, or kuru, and from 32 patietns with a variety of nonspongiform degenerative diseases, with the use of Western blots against an antiserum to a similarly purified fraction made from scrapie-infected hamster brain. Positive reactions occurred in 81 percent of the 31 specimens from the patients with Creutzfeldt-Jakob disease (and in all of the 7 specimens that were stored frozen for less than one year), in 3 of the 4 specimens from the patients with kuru, in 3 of the 4 specimens from the patients with Gerstmann-Straussler-Scheinker syndrome, and in none of the specimens from the patients with other neurologic degenerative disorders, including familial or sporadic Alzheimer''s disease; dementia associated with myoclonus, motor neuron disease, or parkinsonism; and acquired-immunodeficiency-syndrome encephalopathy. Immunologic testing has thus begun to provide a useful and rapid adjunct to neuropathological examinations and animal-transmission experiments for the diagnosis of the spongiform encephalopathies.